Dr. Seema Bibi, FCPS(Obs/Gyn), Associate Professor, Department of Obstetrics/Gynaecology, Liaquat University of Medical & Health Sciences Jamshoro, Sindh, Pakistan.
Dr. Saira Dars, MS(Obs/Gyn), Consultant Gynaecologist, Department of Obstetrics/Gynaecology, Liaquat University Hospital Hyderabad/Jamshoro, Sindh, Pakistan.
Pak J Med Sci. 2013 Apr;29(2):505-8. doi: 10.12669/pjms.292.3211.
Pakistan is among the countries having high prevalence of HCV infection in the population but there is dearth of proper epidemiological data regarding acquisition of HCV infection in the pregnant population. Our objective was to determine the seroprevalence of HCV antibodies in healthy pregnant women and to assess the potential risk factors for HCV infection in HCV positive subjects and in the control group.
This cross sectional and comparative study was conducted from 1(st) January to 31(st) December 2010 in the Department of Obstetrics/Gynaecology Unit-I, Liaquat University Hospital Hyderabad. Sera were collected from all admitted pregnant women and tested for HCV anti bodies using Elisa kits (Abbott, USA). Data were analyzed using SPSS version 16.0 statistical package.
The seroprevalence of HCV among pregnant population was found to be 4.7%. HCV positive women were more likely to have a history of blood transfusion (OR 1.99, 95% CI 1.26- 3.12), History of therapeutic injection use (OR 2.46, 95% CI 1.43-4.26), history of surgery (OR 1.72, 95% CI 1.12-2.66) and history of sharing household products (OR 1.81, 95% CI 1.14-2.87).
HCV seropositive pregnant women were more likely to have a history of blood transfusion, therapeutic injection use, surgery and sharing household items.
巴基斯坦是人群中 HCV 感染流行率较高的国家之一,但缺乏有关孕妇人群中 HCV 感染获得情况的适当流行病学数据。我们的目的是确定健康孕妇中 HCV 抗体的血清流行率,并评估 HCV 阳性者和对照组中 HCV 感染的潜在危险因素。
这是一项于 2010 年 1 月 1 日至 12 月 31 日在海得拉巴 Liaquat 大学医院妇产科第一科进行的横断面和比较研究。从所有入院孕妇中采集血清,使用 Elisa 试剂盒(雅培,美国)检测 HCV 抗体。使用 SPSS 版本 16.0 统计软件包分析数据。
在孕妇人群中,HCV 的血清流行率为 4.7%。HCV 阳性妇女更有可能有输血史(OR 1.99,95%CI 1.26-3.12)、治疗性注射史(OR 2.46,95%CI 1.43-4.26)、手术史(OR 1.72,95%CI 1.12-2.66)和共用家庭用品史(OR 1.81,95%CI 1.14-2.87)。
HCV 血清阳性孕妇更有可能有输血、治疗性注射、手术和共用家庭用品史。